StockMarketWire.com - Genus has reported further jury verdicts in its litigation against Inguran LLC, operating as Sexing Technologies, relating to ABS's Genus Sexed Semen processing technology.

At the trial, in the US District Court for the Western District of Wisconsin where the verdicts were announced yesterday, the jury found that:

(i) ST's patent number 8,206,987 was valid and infringed

(ii) that ST's patent number 8,198,092 was valid and infringed

(iii) that ABS had materially breached the confidentiality obligations under the 2012 semen sorting agreement between the parties.

The jury will now consider a verdict on damages in relation to these matters later this week.

In verdicts delivered on 10 August the jury determined that ABS and Genus had proved that ST had wilfully maintained monopoly power in the market for sexed bovine semen processing in the US since July 2012. The jury also found that Genus had not proved that it had suffered injury as a result of ST's wilful maintenance of monopoly power.




Story provided by StockMarketWire.com